Page
%P
2 Result(s)
-
Article
Open AccessChronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
Respiratory syncytial virus (RSV) is the leading cause of hospitalization among infants in the United States, and the risk for RSV hospitalizations is greater for infants born preterm. Recent studies in preter...
-
Article
Open AccessTrends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Palivizumab is indicated for the prevention of respiratory syncytial virus (RSV) infection in high-risk children. Previous palivizumab utilization studies examined prior authorization claims but did not examin...
